key: cord-0767494-tke9aoqg
authors: Coldrick, Simon; Kelsey, Adrian; Ivings, Matthew J.; Foat, Timothy G.; Parker, Simon T.; Noakes, Catherine J.; Bennett, Allan; Rickard, Helen; Moore, Ginny
title: Modeling and experimental study of dispersion and deposition of respiratory emissions with implications for disease transmission
date: 2022-02-21
journal: Indoor Air
DOI: 10.1111/ina.13000
sha: 45f3f79d9332dfa2a62652e6b5e29ff1c70663e5
doc_id: 767494
cord_uid: tke9aoqg

The ability to model the dispersion of pathogens in exhaled breath is important for characterizing transmission of the SARS‐CoV‐2 virus and other respiratory pathogens. A Computational Fluid Dynamics (CFD) model of droplet and aerosol emission during exhalations has been developed and for the first time compared directly with experimental data for the dispersion of respiratory and oral bacteria from ten subjects coughing, speaking, and singing in a small unventilated room. The modeled exhalations consist of a warm, humid, gaseous carrier flow and droplets represented by a discrete Lagrangian particle phase which incorporates saliva composition. The simulations and experiments both showed greater deposition of bacteria within 1 m of the subject, and the potential for a substantial number of bacteria to remain airborne, with no clear difference in airborne concentration of small bioaerosols (<10 μm diameter) between 1 and 2 m. The agreement between the model and the experimental data for bacterial deposition directly in front of the subjects was encouraging given the uncertainties in model input parameters and the inherent variability within and between subjects. The ability to predict airborne microbial dispersion and deposition gives confidence in the ability to model the consequences of an exhalation and hence the airborne transmission of respiratory pathogens such as SARS‐CoV‐2.

The SARS-CoV-2 pandemic has brought about the need to assess the risks posed by different viral and bacterial transmission routes for hazardous respiratory infections. Knowledge of the relative importance of these different routes is important in understanding the ways in which infection can be transmitted and in determining the best combination of control measures. The two main routes of infectious disease transmission are contact or airborne. Contact transmission may be by direct contact with droplets from a contaminated individual or indirect contact such as touching a contaminated surface (fomite transmission). Airborne transmission arises from pathogen-laden exhaled aerosols which are inhaled. 1 Droplets and aerosols exhaled during normal activities (breathing, talking, singing, coughing, and sneezing) have a range of diameters from <1 μm to >100 μm, and this plays an important role in the routes by which infection could occur. Very large droplets (>100 μm), which may be able to carry a larger microbial load, typically follow a ballistic trajectory and are unlikely to fully evaporate before they deposit on surfaces or on a susceptible individual. Those in smaller diameter ranges experience, proportionally, increased evaporation 2 with a final diameter depending on their initial size and respiratory fluid composition. 3 Studies have suggested 4,5 that the microbial load depends on droplet size and origin, though these relationships remain uncertain and may vary with the type of bacteria or virus. However, the smallest aerosols may be more numerous than large droplets, may remain suspended in the air for relatively long periods, and can be inhaled by a susceptible individual. It is also recognized that dispersion behavior is heavily affected by environmental factors and there is no absolute distinction between the fate of large droplets and aerosols, that is, there is a continuum of behavior across the spectrum of diameters.

The mechanism of airborne transmission has long been acknowledged 6 and plays an important role in the spread of multiple infectious diseases including bacterial pathogens such as tuberculosis, 7 and viral diseases including measles, 8 influenza, 9 and SARS. 10 13 Gregsonet al., 14 ) , demonstrate a wide variation in the number and size of with different vocal activities and between different people. There have also been a number of studies to characterize exhalation flows, 15, 16 which are an important part of defining the initial air movement from the mouth and nose which propel and carry the respiratory droplets and aerosols.

Mathematical modeling can help provide insight into the physics of transmission. Droplet evaporation models, (for example Chen et al., 17 de Oliveira et al., 18 Wei and Li, 19 Xie et al., 2 Walker et al., 20 ) , can be used to explore the influence of environmental factors such as relative humidity, temperature, and diameter change due to evaporation which can influence how droplets behave. One of the limitations of these models is that they are unable to account for factors such as ventilation flows which can influence the transport and deposition of airborne droplets. Other types of models, such as Noakes and Sleigh, 21 Burridge et al., 22 or Jones et al., 23 consider transmission risks as a function of ventilation and pathogen emission rates, but without explicitly modeling the transport and evaporation of droplets.

Computational Fluid Dynamics provides a means of modeling both the droplet physics and the effects of ventilation and can model realistic geometries and their effect on the flow. CFD has been used to model the transmission of infectious diseases, particularly in relation to the SARS and current SARS-CoV-2 outbreaks (e.g. [24] [25] [26] [27] [28] [29] ).

The main benefit of CFD is that it can combine models to describe the interaction of exhaled droplets with environmental flows that influence the behavior of droplets, such as ventilation and thermal effects. CFD modeling can also be used to understand the effects of mitigation methods such as screens, more complex geometries, or the influence of additional people within the environment.

There are, however, numerous challenges to modeling these scenarios using CFD. Droplets of a few microns size in exhalations can evaporate in less than a few seconds. Furthermore, room geometries may be of the order of several meters in dimension and have air change intervals spanning many minutes. Combining these variables and scales into single simulations means that computer run times can become prohibitively long. A further challenge is that the input conditions or source terms (e.g., for exhalations) need to be defined from the outset and these can have a large influence on the results.

Long simulation times can limit the scope of sensitivity analysis that can be carried out on the inputs, and a heavy reliance is made on the strength of input assumptions.

Validation is an important aspect of a modeling study to provide assurance that the assumptions and inputs used in the simulation are appropriate. One of the challenges in validating exhalation models is that the experimental data to cover all aspects from droplet production through transport to deposition, viral load, and infection do not currently exist. For this reason, many previous modeling studies have focussed on validating components of the model as a means of gaining confidence in the overall predictions. A number of studies have compared CFD simulations to exhalation flows from people, 29 idealized experiments with manikins in chambers, 30 and bioaerosol chamber experiments using artificial generation of microbial aerosols from a nebulizer. 31 However, to our knowledge, there are no previous studies that directly compared CFD or droplet model simulation studies with human volunteers exhaling microorganisms.

In the current study, a CFD model of exhalations has been developed and compared to experimental data for surface deposition and air sampling of exhaled bacteria carrying droplets from human participants. The experiments were carried out to quantify the airborne dispersion and deposition of exhaled droplets to provide data for SARS-CoV-2 risk assessments, using detection of respiratory and oral bacteria as a surrogate for virus-laden droplets. Component validation studies were also carried out on individual elements of the CFD model, such as an exhalation jet and single droplet evaporation, to give confidence in the overall predictions from the model. Ten laboratory workers were recruited to carry out the study, with an age range of 21-59 years and gender balance of 50% female and 50% male. Ethical approval for the study was given by the

Group (UKHSA REGG). The participants wore hooded Tyvek suits, shoe coverings, and gloves to reduce shedding of non-oral microorganisms and remained seated facing forwards during the study.

Participants provided a spit sample into a universal container before each experiment, primarily to assess bacterial load. Participants were seated at one end of the chamber and were required to perform a sequential set of activities as follows: cough three times; read out loud the numbers from 1 to 100; inhale and exhale 3 times; sing happy birthday twice loudly; inhale and snort 3 times; read out loud the numbers from 1 to 100; and cough three times.

Samples were collected by air samplers (Andersen 6 stage and Slit samplers) and on 15 Columbia Blood Agar (CBA) settle plates placed at 20 cm intervals directly in front of and to the side of the subject. The Andersen samplers operated at 28.3 L/min and collected particles onto six CBA plates fractionated by particle diameter, though the breakdown by diameter was not included in the results. The slit samplers sampled onto a rotating CBA plate at the same flow rate. Both samplers were operated for a period of 10 min.

Sampler positions are described in the CFD modeling section below.

Immediately before the start of the experiment, the settle plates had their lids removed, the air samplers were switched on automatically and the ventilation was turned off remotely. At the end of each 10min period, the samples were collected and incubated for analysis and the room was ventilated with filtered air for at least 10 min at 180 air changes per hour before the next study.

The number of colony-forming units (CFUs) collected and cultured on each plate was used to define the bacterial deposition onto the surface or the total sampled from the air over the ten-minute experimental period. The type of bacteria and their origin (e.g., organisms from the respiratory tract) that formed the colonies in these assays have not yet been determined. Consequently, a proportion of the colonies detected may have come from other sources.

In line with previous CFD studies, 24, 25, 27, 28, 29 the approach adopted for modeling exhalations is the Euler-Lagrange approach. The Eulerian fluid is modeled on a fixed computational mesh through which the flow field is calculated. The Lagrangian method involves computationally tracking the trajectories of individual droplets as a discrete phase, throughout the calculated flow field from their point of introduction until they deposit on a surface or escape the domain. One of the main benefits of this method is that a fixed count of particles having specific diameters can be modeled. Model outputs such as deposited mass can therefore be calculated for use in further analysis such as in a Quantitative Microbial Risk Assessment (QMRA). 32 While other studies 33, 34 have used a purely Eulerian driftflux framework to study size-resolved particle concentration and deposition, such approaches may not be able to capture trajectories for larger droplets with significant inertia.

The simulations in this study were carried out using the commercial software ANSYS Fluent 19.0. 35 The mixture of air, water vapor, and exhaled carbon dioxide in the Eulerian phase was modeled using a species transport model. The local mass fraction of each species was solved for with a convection-diffusion equation which included a source term for the transfer of water vapor from the Lagrangian droplets to the Eulerian phase. 

The modeled geometry is shown in Figure 1 nodes, which provided reasonable run times. A mesh sensitivity study was carried out, which showed that particle sample results were insensitive to further mesh refinement. An explanation for this behavior is that the sampled results are driven by ballistic deposition or sedimentation, rather than wall-parallel flow, where mesh effects can be important. Increasing the overall mesh density to 2.3 million nodes did not appreciably change the diameter ranges or quantity of particles collected by the settle plates or air samplers. The air samplers mainly collected small particles, which are influenced by the room air flow.

The experiments were carried out at an ambient temperature of 22°C and a relative humidity (RH) of between 44% and 50%. All solid walls were set to the ambient temperature value and the solution initialized with a RH of 50%. As the people in the experiments were fully clothed apart from their face, only the convective heat flux from the subject was modeled, which was applied as a surface heat flux of 25 W/m 2 . This value is similar to that measured by Zhu et al. 29 for a resting subject. The inlet of each air sampler was a circular region, set as an outflow through which air was drawn at a constant volume flow rate, equal to the experimental flow rate. The room was specified as being unventilated during the trials, but there was likely to be a small air exchange through the door seal and ventilation system. A pressure boundary matching the position of the ventilation inlet in the chamber was defined (shown in blue in Figure 1B ) to balance the outflow of air through the samplers. This was specified as a relative pressure of zero and backflow temperature equal to the room temperature. In practice, the leakage flows are unknown. However, the air velocity through this balancing opening was very small and did not influence the flows in the room.

The Reynolds-Averaged Navier-Stokes (RANS) approach was used as it is less computationally intensive than other approaches which aim to directly resolve large-scale turbulent fluctuations. There are numerous RANS turbulence models available which provide good predictions in different types of flows. A challenge is that there is no universally applicable turbulence model which provides optimal predictions in all physical scenarios (e.g., jet flow and near wall flow). Therefore, a level of compromise is often required.

of an isolated turbulent jet, the kω SST model 37 was used across all simulations.

Respiratory particles were modeled using Fluent's multicomponent model. The particles consisted of two components; a solid part (consisting of salts, proteins, and surfactant) specified as nonvolatile and a liquid part (water) which could evaporate into the Eulerian phase. All of the solids were grouped into the non-volatile part, with a volume-weighted density calculated from the average of the non-volatile components 1 as shown in Table 1 . The resultant average solids density was 1830 kg/m 3 , giving the particles initial mass fractions of 98.75% water and 1.25% solids. This water content was similar to the artificial saliva water content described by Walker et al. 20 of 97.9%.

The exchange of momentum between the Eulerian and Lagrangian phases was two-way and accounted for by equating the change of momentum of a particle to the sum of the forces acting on it 38 :

The term on the left is the change in particle momentum (kg m/s) and the forces on the right are the drag force (F D ), buoyancy force (F B ), and other forces (F O ), in (N). Virtual mass and pressure gradient forces were not included as the density of the Eulerian phase was (1) dp p dt = F D + F B + F O much lower than the particle density. 38 The effects of Brownian motion were not modeled as it has been suggested 39 that the effect is only significant for particles ≤0.03 µm, which is considerably smaller than the particles considered in the current study. However, for this scenario, air flows were low and deposition was likely to be dominated by sedimentation for the majority of the particle sizes.

Ceiling and wall deposition rates, where sedimentation does not contribute, were expected to be very small in comparison and were not directly compared in this study.

Particle mass transfer was modeled using the diffusion-controlled model, 38 which assumes that the rate of vaporization of component i is governed by the concentration gradient between the droplet surface and Eulerian phase:

where Sh is the Sherwood number (-), which in turn depends on the Reynolds (-) and Schmidt (-) numbers, D i is the diffusion coefficient (m 2 /s), d p is the particle diameter (m), M w,i is the molecular weight of the component (kg/kmol), and C i,s and C i,∞ are the concentrations (kmol/ m 3 ) at the particle surface and in the Eulerian continuum, respectively.

Heat transfer to the particle was modeled using the multicomponent energy equation, accounting for heat transfer by convection and vaporization 38 :

where m p is the particle mass (kg), T p is the particle temperature (K),

T ∞ is the continuum temperature (K), C p is the particle heat capacity 

The surface concentration of a solution particle is affected by its composition and the departure from an ideal solution becomes important, especially at high solute fractions. Drying of respiratory droplets has been extensively studied, and there are numerous approaches that can be taken. 18, 20 In the current work, the model of Walker et al. 20 was implemented to define the particle surface vapor concentration. For a multicomponent particle, the surface concentration can be given by 38 :

where γ i is the activity coefficient (-), χ i is the component mole fraction (-), φ i is the fugacity coefficient (-), P sat , i is the saturation vapor pressure (Pa) at temperature T p (K), and Z V is the vapor compressibility (-). For an ideal gas at low pressure, the fugacity coefficient and compressibility are assumed to be equal to 1. Non-ideal solution effects are accounted for through the activity, α i (-), which is the product of the activity coefficient and component mole fraction 42 :

where P i is the modified vapor pressure. Walker et al. 20 

The geometry of the mouth during coughing, talking, and singing is variable and highly uncertain. Rather than attempt to capture these intricacies, exhalations were assumed to originate only from the mouth region which was defined as a circular orifice with a fixed diameter, depending on the activity. A source term was applied over this opening and consisted of a gaseous "carrier" flow with a specified temperature, RH, and transient velocity profile at a particular angle ( Figure 2 ), along with a simultaneous injection of particles. It is known that jet dispersion results are sensitive to the inlet turbulence intensity. There is little available information on this quantity for this specific application, so the intensity and length scale were set as 10% and 0.01 m, respectively.

The details of the modeled carrier flow are given in Table 2 . 

The Bronchiolar, Laryngeal, and Oral "BLO" model 13 and Cn are shown in Table 3 ; these are the values suggested by

Stettler et al. 1 to describe speaking.

To describe the particles in an exhalation, the droplet diameter range was divided into size bins, allowing the number of particles per cm 3 of exhaled gas and vapor in each size bin to be calculated.

The number of particles exhaled for each size bin during an exhalation was the product of the exhalation volume, derived from the

� F I G U R E 2 Initial jet expansion angles viewed from the side and front. The front projection is the same for both speaking and coughing parameters in Table 2 , and the count density for the size bin. The total number of particles was distributed throughout the duration of each exhalation, and particles were introduced during each of the timesteps used to resolve the exhalation flow. It was assumed that the particle size distribution does not change during exhalations 48 and that the number of particles exhaled varied only with the exhalation flow rate, effectively representing a constant concentration.

It was also assumed that the particle velocity vector at the point of injection was equal to the carrier flow velocity at that point. Particles were introduced at random locations over the mouth area and at a random time fraction of each injection time step.

The number of particles emitted during each timestep was calculated as the fraction of the total volume exhaled during the duration of the timestep. Speaking and singing were described by the uniform flow rates given in Table 2 , and the exhaled droplets were distrib- The BLO model only gives particle size distributions for speaking and coughing. To reflect the fact that singing will produce a different source characteristic from speaking, a modified singing source (Source 4 in Table 2 In a Lagrangian tracking simulation, each computational particle represents a statistical "parcel" of particles. For computational efficiency, a limited number of parcels are usually modeled and each parcel typically represents many individual particles. It is usually advantageous when simulating sprays to track a "statistically significant" number of particles. 49 broken into 25 equal increments on a base 10 log scale. In some of the increments in the oral mode and between the oral mode and the smaller diameters of the bronchiolar and laryngeal modes, the total number of particles in the increments was small. Sampling from the distribution meant that some increments contained no particles or only one or two particles. To improve the representation of the distribution, simulations were performed using 10 times the number of parcels of particles (referred to as 10× oversample) and the results were scaled accordingly. An additional simulation of one cough was carried out with 100× oversample, but this did not significantly change deposition patterns compared to the 10× oversample simulation. Therefore, 10× oversample counts were used for subsequent simulations. The total parcel counts are shown in Table 4 .

Simulating all the activities sequentially (i.e., coughing, speaking, singing) in a single simulation would result in having to track a large number of particles and would also incur a substantial computational overhead from having to resolve in time each activity in the sequence. For practical purposes, the simulations were carried out individually, where single simulations of one activity (coughing, talking, or singing) were run with subsequent output of particle fates over a 10-min period, corresponding to the experiment, and the particle data were concatenated in post-processing as shown in Table 5 . One drawback with this method of simulation 

The experimental data were presented as the mean number of bacterial colony-forming units (CFUs) recovered from each sample plate and aerosol sampler, with error bars to represent one standard deviation. This was considered an appropriate measure for comparison against computational results. It should be noted that the generation of bacteria was variable by person; one participant generated 39% of all deposited bacteria and 29% of airborne particles, and 50% of participants generated 80% of deposited and airborne bacteria.

In comparing the computational results to experimental data, it was assumed that the collection efficiency of the aerosol samplers was 100% for all sizes. Sample results were compared with the predicted concatenated cumulative particle dataset, where for the idealized case it is assumed that each sampled computational particle results in a bacterial colony and the number of sampled computational particles can be directly compared to the experimental data. For the k th sample location, the total number of particles, N k , can be defined as follows:

where N parcels,k is the number of sampled parcels and N p is the number of particles per parcel. An alternative measure is to compute relative counts which can be used to assess the level of dispersion among the sample locations. The first centerline settle plate (PCL1) was chosen to normalize the results, to give a normalized count, N norm,k , as follows:

Results from the experiment were normalized in the same way, using the count on the first settle plate. The viability of airborne bioaerosols is influenced by a number of factors 51 so the count of modeled particles may tend to overestimate the number of viable particles emitted. In this case, viable refers to the initial probability of a particle containing viable material, it does not account for further effects such as culturability, damage due to drying, or the possibility that the final dried particle diameter might be smaller than the dimension of a bacteria. The mean number of colony-forming units in a particle of initial diameter, d 0 , can be expressed by 52 :

where C b is the mean number of aerobic bacteria cultured and was estimated from the experiments to be 7.37 × 10 7 CFU/ml (SD: ±6.43 × 10 7 , range 1.5 × 10 7 CFU/ml to 2.37 × 10 8 CFU/ml). Assuming a Poisson distribution, the probability that a particle will contain at least one CFU is given by 52 : Figure 3 is a plot showing the variation of P with particle diameter for the range of C b given above. The number of viable particles, N viable,k , at the k th sample location was calculated by:

Comparisons between the measured experimental microbial data and simulated particle counts in air and on surfaces are shown in Results for the centerline settle plates are shown in Figure 4A , using the idealized particle count given by Equation 8 . Particle count on the closer plates is overpredicted with those on the first plate overpredicted by a factor of five. One reason for this overprediction is that every particle that lands on a plate is counted in the simulation, whereas in the experiment, only those that form a culture can be recorded. The modified source terms for speaking and singing resulted in slightly increased deposition on the nearest plates, due to the increased particle input velocity. However, most of the particles deposited on the plates were from the coughing activity and the contribution of speaking and singing to the total count on the plates remained small. Figure 4B shows a comparison of the viable particles for the centerline plates, using Equation 12 . The results are the same as the idealized case for the first two plates where the rapid deposition of larger particles dominate. Further away, the predicted viable count decreases compared to the idealized case. The results with the normalized particle count using Equation 9 shown

in Figure 3C show that the simulated rate of decay with distance is steeper than seen in the experiments with a greater number of bacteria collected on the more distant plates than predicted. This is likely to be a result of the variability within the experiments, including individual differences in exhalation velocities and particle size ranges which was not fully replicated in the simulation. The simulated input carrier flow was fixed in each case such that variability was only included in the particle oversampling, which only accounts for part of the overall variability. The order of magnitude difference in counts on the plates observed between individuals is not represented in the model. In the model, no particles were predicted on the off-axis plates to the right of the subject and so are not shown in the figures. A small number of particles were collected on these plates in the experiment.

Results for the Andersen air samplers are shown in Figure 4D -F. The model overpredicted absolute counts at the inline samplers (AS1, AS2), see Figure 4D , while no particles were predicted to be collected by the off-axis sampler to the left of the person (AS3)

although samples were collected in the experiments. Figure 4E shows the adjusted results for the Andersen air samplers, accounting for the viability of the particles are significantly different. In the model, these samplers collected only the smallest particles (<10 μm), which have a lower probability of containing viable bacteria. It is likely that these results are heavily influenced by the initial particle size distribution. Figure 4F shows that relative collection was around three times higher at the 1 m sampler in the Finally, the intra-person variability would have resulted in a wider spread of data, while parameters such as the carrier flow and projection angles were fixed in the simulations.

Variation of the probability, P, that a particle will contain at least one CFU with particle diameter | 11 of 16 COLDRICK et aL. Figure 6 shows the partitioning of sampled particle sizes from the CFD simulations on the surfaces and collected in the air samples, for each individual activity. In each case, the count refers to the number of parcels sampled at each location and these are compared with the input number of parcels shown in blue. The diameters in Figure 6 are the initial diameters of the particles at their time of injection, for both input and sampled particles; although the diameter change due to evaporation is modeled, the comparison is made using the initial diameters to illustrate the ultimate fate of different sizes of exhaled particles. For clarity, the surface samples were grouped together into "Centreline plates" (orange), "Centreline tables" (purple), "Right table" (green), and "Floor" (light blue). The right hand plates are not included in these plots, because no particles were predicted to deposit there. The air samples are recorded at "AS1" (orange), "AS2" (yellow), "SS1" (purple), and "SS2"

(green), see Figure 1B . The general trend is that the larger particles, representing the oral mode of production, were deposited on surfaces. The predicted air samples were generated entirely by the bronchiolar and laryngeal modes from the input BLO particle distribution. The exception was the cough, in which most of the full range of sizes was projected on to the surfaces. This partitioning of diameters between surfaces and air samples appears to be, in part, due to the droplet diameter distribution in the BLO model which has a pronounced dip in the initial diameter distribution, around 30 µm, between B and L, and O modes. for coughing, while more were registered at the furthest sampler (SS2) for speaking and singing.

The CFD-based exhalation model developed in this study takes into account exhalation flows, particle size distributions, evaporation ef- The discrepancies seen off-axis require further investigation to understand the variability in the experimental study deposition results.

The simulations are based on a mostly uniform set of conditions and therefore will not capture much of the intra-and inter-person variability seen in the volunteer experiments. In a modeling study, the effects of this variability can be further understood through a sensitivity analysis of the type reported by Ho. 26 However, this would be a significant computational undertaking without making numerous simplifying assumptions.

The approach taken in the current modeling study was to implement a practicable estimate for a source term for different exhalation activities, and to simulate activities separately and sum the effects rather than simulate sequentially. Some variability has been included through the use of 10-time oversampled particles, giving a greater spread of particle injection times and velocities. However, the off-axis samples are likely to be influenced by aspects of the ventilation flow that were not accounted for in the simulations where it was assumed that the flow of air drawn by the samplers was balanced by that through a single vent panel. In practice, there will have been small but finite air flows through the doors and other ventilation controls which may have increased mixing within the chamber.

In addition, the thermal conditions in the experiment may differ from the idealized case simulated and the sequence of vocal activities in the experiment would contribute to the overall mixing in the room.

The model results depend on a number of assumptions and input models, including the need to specify emission rates of respiratory droplets and aerosols and exhalation parameters such as velocity and angle of the jet. The use of the BLO model 13 resulted in a fairly clear distinction between particles that would remain airborne and those which deposit relatively quickly,however, it is noted that the bimodal distribution is not seen in other measured data 12 and may be related to how the different size categories of respiratory particles are measured and sampled. The BLO model is based on data collected over multiple studies, with multiple volunteers and using different measuring techniques. It is representative across the range of measured particle sizes. However, it is recognized that there is an inherent variability in such measurements and that other particle size distributions could be used. The model also assumed that microorganisms were uniformly distributed by volume, which may not be the case if there is preferential aerosolization into smaller or larger sizes due to hydrophobicity effects, or clumping of bacteria.

Despite these uncertainties, the model results showed similar behavior to the experiments in that deposition was greater at 1 m than at 1-2 m from source and the results from the air samplers suggested that fine (approx. 0.4-10 µm) particles would eventually be uniformly suspended in the room given sufficient mixing time.

F I G U R E 7 Comparison of model particle counts for the initial (blue) and sampled (orange) diameters. In addition to deposited and extracted particles, any suspended particles at the end of the simulations were counted as sampled. The darker shaded bars are where both input and samples overlap This suggests that a computational model based on parameters from measured aerosol and exhalation data and the physics of droplet evaporation can provide realistic representations of the fate of exhaled microbial particles.

The model presented here is compared to oral and respiratory bacteria rather than the SARS-CoV-2 virus, as it was not feasible to carry out experiments with COVID-19 patients. Although bacteria are larger than viruses (typically 1-2 μm in diameter compared to around 0.07-0.09 μm), respiratory aerosols carrying virus will also carry the same salts, surfactants, and proteins in our study and will also carry oral and respiratory tract bacteria. Viral aerosols may be able to evaporate to smaller sizes, but many will still be likely to be a similar size 

A CFD model of exhalations has been developed and compared with experimental data for the dispersion of bacteria from subjects F I G U R E 8 Ratio of the modeled number of air sampled particles to the input number of particles, by diameter, for (A) a cough, (B) talking, and (C) singing. The horizontal lines represent the ratio of sampled to input CO 2 concentration. The CO 2 ratios at AS1 and SS1 for one cough are overlaid coughing, speaking, and singing in a room. On the basis of normalized particle count, to assess the relative dispersion among the sample locations, the model performed reasonably well, particularly given the uncertainties involved at all stages of the modeling.

There was also relatively good agreement in the ratio of particle counts among the surface samples and air samples in front of the subject, although deposition on sample plates close to the participants and the rate of reduction of particle count with distance were both overpredicted. Off-axis dispersion was relatively poorly predicted, suggesting that the dispersion in the test chamber as a whole was being underpredicted, probably due to air movement during the experiments that were not accounted for in the model. showed similar behavior to the experiments in that significant deposition was recorded at around 1 m from the source but then dropped off quickly over the next meter. The results from the air samplers suggested that fine particles would eventually be uniformly suspended in the test chamber given sufficient mixing time. Comparison of predicted and experimental results was encouraging and has provided confidence that the computational methodology can be used for more extensive airborne transmission studies. In particular, an aim for future work would be to determine how different source terms translate into viral loadings in the environment.

The authors would like to acknowledge funding provided through PROTECT, the National Core Study on Transmission and the Environment which partially funded this work. The contents of this paper, including any opinions and/or conclusions expressed, are those of the authors alone and do not necessarily reflect HSE policy. 

Source terms for benchmarking models of SARS-CoV-2 transmission via aerosols and droplets

How far droplets can move in indoor environments-revisiting the Wells evaporationfalling curve

Toward understanding the risk of secondary airborne infection: emission of respirable pathogens

Viral load of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) in respiratory aerosols emitted by patients with coronavirus disease 2019 (COVID-19) while breathing, talking, and singing

Measurements of airborne influenza virus in aerosol particles from human coughs

House of Commons (Ventilation)

Airborne pulmonary tuberculosis

Airborne transmission of measles in a physician's office

Review of aerosol transmission of influenza A virus

Role of air distribution in SARS transmission during the largest nosocomial outbreak in Hong Kong

World Health Organisation Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief

The size and the duration of air-carriage of respiratory droplets and droplet-nuclei

Modality of human expired aerosol size distributions

Comparing the respirable aerosol concentrations and particle size distributions generated by singing, speaking and breathing

Flow dynamics and characterization of a cough

Characterizing exhaled airflow from breathing and talking

Short-range airborne route dominates exposure of respiratory infection during close contact

Evolution of spray and aerosol from respiratory releases: theoretical estimates for insight on viral transmission

Enhanced spread of expiratory droplets by turbulence in a cough jet

Accurate representations of the microphysical processes occurring during the transport of exhaled aerosols and droplets

Mathematical models for assessing the role of airflow on the risk of airborne infection in hospital wards

Predictive and retrospective modelling of airborne infection risk using monitored carbon dioxide

Modelling uncertainty in the relative risk of exposure to the SARS-CoV-2 virus by airborne aerosol transmission in well mixed indoor air

Some questions on dispersion of human exhaled droplets in ventilation room: answers from numerical investigation

Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: a numerical study

Modeling airborne pathogen transport and transmission risks of SARS-CoV-2

Dispersion of evaporating cough droplets in tropical outdoor environment

Modeling the evaporation and dispersion of airborne sputum droplets expelled from a human cough

Study on transport characteristics of saliva droplets produced by coughing in a calm indoor environment

CFD analysis of the human exhalation flow using different boundary conditions and ventilation strategies

Bioaerosol deposition in single and two-bed hospital rooms: a numerical and experimental study

Quantitative microbial risk assessment (QMRA) of occupational exposure to SARS-CoV-2 in wastewater treatment plants

Modeling particle distribution and deposition in indoor environments with a new drift-flux model

Refinement and testing of the drift-flux model for indoor aerosol dispersion and deposition modelling

Release 19.0, User's Guide

NASA Man-Systems Integration Standards Revision B, Volume I, Section 3 Anthropometry and Biomechanics

Mentor F. Two-equation eddy-viscosity turbulence models for engineering applications

Release 19.0, Theory Guide

Brownian diffusion of submicrometer particles in the viscous sublayer

Aspects of computer simulation of liquidfuelled combustors

Towards quantitative prediction of aerosol deposition from turbulent flows

Atmospheric Chemistry and Physics: From Air Pollution to Climate Change

The evaporation of airborne droplets

Interaction of aerosol particles composed of protein and salts with water vapor: hygroscopic growth and microstructural rearrangement

Dittmer DS eds. Respiration and Circulation

The mechanism of breath aerosol formation

Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities

Characterizations of particle size distribution of the droplets exhaled by sneeze

How many particles for my Lagrangian simulations?

Modeling the fate of expiratory aerosols and the associated infection risk in an aircraft cabin environment

Assessing the airborne survival of bacteria in populations of aerosol droplets with a novel technology

Size distribution of virus laden droplets from expiratory ejecta of infected subjects

Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols

Respiratory aerosols and droplets in the transmission of infectious diseases

Relative contributions of transmission routes for covid-19 among healthcare personnel providing patient care

Mechanistic transmission modeling of covid-19 on the diamond princess cruise ship demonstrates the importance of aerosol transmission

Modeling and experimental study of dispersion and deposition of respiratory emissions with implications for disease transmission